Analysis | Samples | Factors | Units |
---|---|---|---|
Reversed phase NEGATIVE ION MODE | CT RagA GTP 1 | time (h):0 | Dead E coli treatment:no | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:RagA GTP mutant | peak area |
Reversed phase NEGATIVE ION MODE | CT RagA GTP 2 | time (h):0 | Dead E coli treatment:no | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:RagA GTP mutant | peak area |
Reversed phase NEGATIVE ION MODE | CT RagA GTP 3 | time (h):0 | Dead E coli treatment:no | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:RagA GTP mutant | peak area |
Reversed phase NEGATIVE ION MODE | CT RagA GTP 4 | time (h):0 | Dead E coli treatment:no | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:RagA GTP mutant | peak area |
Reversed phase NEGATIVE ION MODE | CT WT 1 | time (h):0 | Dead E coli treatment:no | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase NEGATIVE ION MODE | CT WT 1 + Conca | time (h):0 | Dead E coli treatment:no | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase NEGATIVE ION MODE | CT WT 2 | time (h):0 | Dead E coli treatment:no | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase NEGATIVE ION MODE | CT WT 2 + Conca | time (h):0 | Dead E coli treatment:no | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase NEGATIVE ION MODE | CT WT 3 | time (h):0 | Dead E coli treatment:no | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase NEGATIVE ION MODE | CT WT 3 + Conca | time (h):0 | Dead E coli treatment:no | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase NEGATIVE ION MODE | CT WT 4 | time (h):0 | Dead E coli treatment:no | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase NEGATIVE ION MODE | CT WT 4 + Conca | time (h):0 | Dead E coli treatment:no | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase NEGATIVE ION MODE | WT 1 18h + Conca | time (h):18 | Dead E coli treatment:yes | inhibitor:150 nM concanamycin A | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase NEGATIVE ION MODE | WT 2 18h + Conca | time (h):18 | Dead E coli treatment:yes | inhibitor:150 nM concanamycin A | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase NEGATIVE ION MODE | WT3 18h + Conca | time (h):18 | Dead E coli treatment:yes | inhibitor:150 nM concanamycin A | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase NEGATIVE ION MODE | WT 4 18h + Conca | time (h):18 | Dead E coli treatment:yes | inhibitor:150 nM concanamycin A | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase NEGATIVE ION MODE | WT 1 18h + Bafilo | time (h):18 | Dead E coli treatment:yes | inhibitor:50 nM bafilomycin A1 | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase NEGATIVE ION MODE | WT 2 18h + Bafilo | time (h):18 | Dead E coli treatment:yes | inhibitor:50 nM bafilomycin A1 | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase NEGATIVE ION MODE | WT3 18h + Bafilo | time (h):18 | Dead E coli treatment:yes | inhibitor:50 nM bafilomycin A1 | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase NEGATIVE ION MODE | WT 4 18h + Bafilo | time (h):18 | Dead E coli treatment:yes | inhibitor:50 nM bafilomycin A1 | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase NEGATIVE ION MODE | RagA GTP 1 18h | time (h):18 | Dead E coli treatment:yes | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:RagA GTP mutant | peak area |
Reversed phase NEGATIVE ION MODE | RagA GTP 2 18h | time (h):18 | Dead E coli treatment:yes | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:RagA GTP mutant | peak area |
Reversed phase NEGATIVE ION MODE | RagA GTP 3 18h | time (h):18 | Dead E coli treatment:yes | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:RagA GTP mutant | peak area |
Reversed phase NEGATIVE ION MODE | RagA GTP 4 18h | time (h):18 | Dead E coli treatment:yes | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:RagA GTP mutant | peak area |
Reversed phase NEGATIVE ION MODE | WT 1 18h | time (h):18 | Dead E coli treatment:yes | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase NEGATIVE ION MODE | WT 2 18h | time (h):18 | Dead E coli treatment:yes | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase NEGATIVE ION MODE | WT3 18h | time (h):18 | Dead E coli treatment:yes | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase NEGATIVE ION MODE | WT 4 18h | time (h):18 | Dead E coli treatment:yes | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase NEGATIVE ION MODE | WT 1 6h + Conca | time (h):6 | Dead E coli treatment:yes | inhibitor:150 nM concanamycin A | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase NEGATIVE ION MODE | WT 2 6h + Conca | time (h):6 | Dead E coli treatment:yes | inhibitor:150 nM concanamycin A | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase NEGATIVE ION MODE | WT 3 6h + Conca | time (h):6 | Dead E coli treatment:yes | inhibitor:150 nM concanamycin A | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase NEGATIVE ION MODE | WT 4 6h + Conca | time (h):6 | Dead E coli treatment:yes | inhibitor:150 nM concanamycin A | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase NEGATIVE ION MODE | WT 1 6h + Bafilo | time (h):6 | Dead E coli treatment:yes | inhibitor:50 nM bafilomycin A1 | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase NEGATIVE ION MODE | WT 2 6h + Bafilo | time (h):6 | Dead E coli treatment:yes | inhibitor:50 nM bafilomycin A1 | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase NEGATIVE ION MODE | WT 3 6h + Bafilo | time (h):6 | Dead E coli treatment:yes | inhibitor:50 nM bafilomycin A1 | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase NEGATIVE ION MODE | WT 4 6h + Bafilo | time (h):6 | Dead E coli treatment:yes | inhibitor:50 nM bafilomycin A1 | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase NEGATIVE ION MODE | RagA GTP 1 6h | time (h):6 | Dead E coli treatment:yes | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:RagA GTP mutant | peak area |
Reversed phase NEGATIVE ION MODE | RagA GTP 2 6h | time (h):6 | Dead E coli treatment:yes | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:RagA GTP mutant | peak area |
Reversed phase NEGATIVE ION MODE | RagA GTP 3 6h | time (h):6 | Dead E coli treatment:yes | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:RagA GTP mutant | peak area |
Reversed phase NEGATIVE ION MODE | RagA GTP 4 6h | time (h):6 | Dead E coli treatment:yes | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:RagA GTP mutant | peak area |
Reversed phase NEGATIVE ION MODE | WT 1 6h | time (h):6 | Dead E coli treatment:yes | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase NEGATIVE ION MODE | WT 2 6h | time (h):6 | Dead E coli treatment:yes | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase NEGATIVE ION MODE | WT 3 6h | time (h):6 | Dead E coli treatment:yes | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase NEGATIVE ION MODE | WT 4 6h | time (h):6 | Dead E coli treatment:yes | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase POSITIVE ION MODE | CT RagA GTP 1 | time (h):0 | Dead E coli treatment:no | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:RagA GTP mutant | peak area |
Reversed phase POSITIVE ION MODE | CT RagA GTP 2 | time (h):0 | Dead E coli treatment:no | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:RagA GTP mutant | peak area |
Reversed phase POSITIVE ION MODE | CT RagA GTP 3 | time (h):0 | Dead E coli treatment:no | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:RagA GTP mutant | peak area |
Reversed phase POSITIVE ION MODE | CT RagA GTP 4 | time (h):0 | Dead E coli treatment:no | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:RagA GTP mutant | peak area |
Reversed phase POSITIVE ION MODE | CT WT 1 | time (h):0 | Dead E coli treatment:no | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase POSITIVE ION MODE | CT WT 1 + Conca | time (h):0 | Dead E coli treatment:no | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase POSITIVE ION MODE | CT WT 2 | time (h):0 | Dead E coli treatment:no | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase POSITIVE ION MODE | CT WT 2 + Conca | time (h):0 | Dead E coli treatment:no | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase POSITIVE ION MODE | CT WT 3 | time (h):0 | Dead E coli treatment:no | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase POSITIVE ION MODE | CT WT 3 + Conca | time (h):0 | Dead E coli treatment:no | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase POSITIVE ION MODE | CT WT 4 | time (h):0 | Dead E coli treatment:no | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase POSITIVE ION MODE | CT WT 4 + Conca | time (h):0 | Dead E coli treatment:no | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase POSITIVE ION MODE | WT 1 18h + Conca | time (h):18 | Dead E coli treatment:yes | inhibitor:150 nM concanamycin A | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase POSITIVE ION MODE | WT 2 18h + Conca | time (h):18 | Dead E coli treatment:yes | inhibitor:150 nM concanamycin A | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase POSITIVE ION MODE | WT3 18h + Conca | time (h):18 | Dead E coli treatment:yes | inhibitor:150 nM concanamycin A | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase POSITIVE ION MODE | WT 4 18h + Conca | time (h):18 | Dead E coli treatment:yes | inhibitor:150 nM concanamycin A | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase POSITIVE ION MODE | WT 1 18h + Bafilo | time (h):18 | Dead E coli treatment:yes | inhibitor:50 nM bafilomycin A1 | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase POSITIVE ION MODE | WT 2 18h + Bafilo | time (h):18 | Dead E coli treatment:yes | inhibitor:50 nM bafilomycin A1 | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase POSITIVE ION MODE | WT3 18h + Bafilo | time (h):18 | Dead E coli treatment:yes | inhibitor:50 nM bafilomycin A1 | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase POSITIVE ION MODE | WT 4 18h + Bafilo | time (h):18 | Dead E coli treatment:yes | inhibitor:50 nM bafilomycin A1 | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase POSITIVE ION MODE | RagA GTP 1 18h | time (h):18 | Dead E coli treatment:yes | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:RagA GTP mutant | peak area |
Reversed phase POSITIVE ION MODE | RagA GTP 2 18h | time (h):18 | Dead E coli treatment:yes | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:RagA GTP mutant | peak area |
Reversed phase POSITIVE ION MODE | RagA GTP 3 18h | time (h):18 | Dead E coli treatment:yes | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:RagA GTP mutant | peak area |
Reversed phase POSITIVE ION MODE | RagA GTP 4 18h | time (h):18 | Dead E coli treatment:yes | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:RagA GTP mutant | peak area |
Reversed phase POSITIVE ION MODE | WT 1 18h | time (h):18 | Dead E coli treatment:yes | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase POSITIVE ION MODE | WT 2 18h | time (h):18 | Dead E coli treatment:yes | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase POSITIVE ION MODE | WT3 18h | time (h):18 | Dead E coli treatment:yes | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase POSITIVE ION MODE | WT 4 18h | time (h):18 | Dead E coli treatment:yes | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase POSITIVE ION MODE | WT 1 6h + Conca | time (h):6 | Dead E coli treatment:yes | inhibitor:150 nM concanamycin A | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase POSITIVE ION MODE | WT 2 6h + Conca | time (h):6 | Dead E coli treatment:yes | inhibitor:150 nM concanamycin A | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase POSITIVE ION MODE | WT 3 6h + Conca | time (h):6 | Dead E coli treatment:yes | inhibitor:150 nM concanamycin A | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase POSITIVE ION MODE | WT 4 6h + Conca | time (h):6 | Dead E coli treatment:yes | inhibitor:150 nM concanamycin A | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase POSITIVE ION MODE | WT 1 6h + Bafilo | time (h):6 | Dead E coli treatment:yes | inhibitor:50 nM bafilomycin A1 | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase POSITIVE ION MODE | WT 2 6h + Bafilo | time (h):6 | Dead E coli treatment:yes | inhibitor:50 nM bafilomycin A1 | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase POSITIVE ION MODE | WT 3 6h + Bafilo | time (h):6 | Dead E coli treatment:yes | inhibitor:50 nM bafilomycin A1 | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase POSITIVE ION MODE | WT 4 6h + Bafilo | time (h):6 | Dead E coli treatment:yes | inhibitor:50 nM bafilomycin A1 | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase POSITIVE ION MODE | RagA GTP 1 6h | time (h):6 | Dead E coli treatment:yes | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:RagA GTP mutant | peak area |
Reversed phase POSITIVE ION MODE | RagA GTP 2 6h | time (h):6 | Dead E coli treatment:yes | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:RagA GTP mutant | peak area |
Reversed phase POSITIVE ION MODE | RagA GTP 3 6h | time (h):6 | Dead E coli treatment:yes | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:RagA GTP mutant | peak area |
Reversed phase POSITIVE ION MODE | RagA GTP 4 6h | time (h):6 | Dead E coli treatment:yes | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:RagA GTP mutant | peak area |
Reversed phase POSITIVE ION MODE | WT 1 6h | time (h):6 | Dead E coli treatment:yes | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase POSITIVE ION MODE | WT 2 6h | time (h):6 | Dead E coli treatment:yes | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase POSITIVE ION MODE | WT 3 6h | time (h):6 | Dead E coli treatment:yes | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |
Reversed phase POSITIVE ION MODE | WT 4 6h | time (h):6 | Dead E coli treatment:yes | inhibitor:none | Sample source:murine bone marrow derived macrophages | genotype:WT | peak area |